SG Americas Securities »

Revance Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $550k 63k 8.79
2023-03-31 $694k 22k 32.21
2022-12-31 $138k 7.5k 18.49
2022-09-30 $308k 11k 27.01
2021-09-30 $946k 34k 27.86
2021-06-30 $219k 7.4k 29.66
2021-03-31 $391k 14k 27.94
2020-12-31 $134k 4.7k 28.28
2020-09-30 $1.2M 49k 25.14
2020-06-30 $616k 25k 24.42
2020-03-31 $146k 9.9k 14.79
2019-12-31 $129k 7.9k 16.28
2019-03-31 $173k 11k 15.75
2017-09-30 $144k 5.2k 27.53
2016-12-31 $222k 11k 20.68
2016-03-31 $128k 7.4k 17.41
2015-06-30 $105k 3.3k 31.91